Q4-FY26 · Pushpa Pummani
The benefits of these investments are now beginning to materialize.
SAKAR / language trends
Read confidence between the lines.
Sakar Healthcare · tone and specificity signals across the available quarters.
Research layer active
Language signals
What changed in management language.
tracked
Q4-FY26 · Pushpa Pummani
We have already signed more than 60 oncology business contracts with over 35 discussions currently ongoing.
Q4-FY26 · Pushpa Pummani
The accord intact portfolio alone comprising 10 oncology products to be manufactured by SAK represents a potential opportunity of rupees 50 cr to 100 cr.